Non-Small Cell Lung Cancer (NSCLC)
Conditions
Interventions
(Part II and III )progression group and non-progression group:None
(Part I)Training set and validation set:None
Sponsors
Shanghai Geriatric Medical Center
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Part I case: advanced stage IIIB-IV non-small cell lung cancer patients; 2.Part I: Chest thin-slice enhanced CT (slice thickness 1mm, DICOM images); 3.Part II and III cases :Patients with advanced stage IIIB-IV non-small cell lung cancer (NSCLC) who received immunotherapy, with complete clinical and pathological data (gender, age, smoking history, family history, TNM staging, laboratory tests, treatment regimen, time and cause of disease progression or death, etc.); pathological type, genetic mutation detection. 4.Part II and III cases :Chest thin-slice CT scans (slice thickness 1mm, DICOM images) were performed within one week before immunotherapy. 5.Part II and III cases :followed up with enhanced CT every 4-6 weeks after treatment.
Exclusion criteria
Exclusion criteria: 1.postoperative patients, the pulmonary lesions are metastatic tumors. 2.No pathological results obtained or lost to follow-up;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Combined prediction AUC values;Dice coefficient for vessel segmentation; | — |
Countries
China
Contacts
Public ContactShen Leilei
Shanghai Geriatric Medical Center
Outcome results
None listed